"It is really, really hard," he said.
直到Vosoritide的获批，才让ACH治疗迈入一个全新的靶向治疗时代。它是一种C型利钠肽(CNP)类似物，通过结合NPR-B进而降低FGFR3的活性来促进生长。临床结果试验显示：相较于安慰剂，每日皮下注射15 μg/kg的Vosoritide，受试者平均年身高增加了1.57厘米。
。业内人士推荐搜狗输入法下载作为进阶阅读
One of the interesting things about the ATM is when, exactly, it pops up in the
What is this page?